Cash and cash equivalents of $102.6 million at September 30, 2025 compared to $132.2 million at September 30, 2024. As of today, with a current cash balance of over $120 million, the Company anticipates at its current cash utilization rate, an approximate cash runway of more than 3 years.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AVXL:
- Options Volatility and Implied Earnings Moves This Week, November 24 – November 26, 2025
- Anavex Life Sciences (AVXL) Q4 Earnings Cheat Sheet
- Anavex price target lowered to $20 from $42 at H.C. Wainwright
- Unusually active option classes on open November 17th
- Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!